NKGEN BIOTECH
LIVE

Serial Number

90514320

Owner

NKGEN BIOTECH, INC.

Attorney

Deborah L. Corpus

First Use Date

Apr 6, 2021

Filing Date

Feb 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NKGEN BIOTECH Trademark

Serial Number: 90514320 • Registration: 6958359

NKGEN BIOTECH is a trademark filed by NKGEN BIOTECH, INC. on February 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NKGEN BIOTECH, INC. (4 trademarks)

Cheoncheon-dong,Res&Bus Foundation Ctr
Gyeonggi-do 16419 , KR

Entity Type: 03

NKMAX Co., Ltd. (12 trademarks)

6F/1F SNUH Health Care Innovation Park
Gyeonggi-do 13605 , KR

Entity Type: 03

Trademark Details

Filing Date

February 5, 2021

Registration Date

January 17, 2023

First Use Anywhere

April 6, 2021

First Use in Commerce

April 6, 2021

Published for Opposition

December 21, 2021

Goods & Services

pharmaceutical preparations for animals; Pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders

development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 6, 2024 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 4, 2023 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 17, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 10, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 9, 2022 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 16, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 13, 2022 GNFN
FINAL REFUSAL E-MAILED
Oct 13, 2022 GNFR
SU - FINAL REFUSAL - WRITTEN
Oct 13, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2022 CRFA
ASSIGNED TO LIE
Sep 21, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 14, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 7, 2022 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 6, 2022 AITU
USE AMENDMENT FILED
May 20, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
May 20, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 15, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 10, 2021 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 11, 2021 NWOS
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Mar 24, 2021 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 24, 2021 PARI
NEW APPLICATION ENTERED
Feb 9, 2021 NWAP